Perennial Allergic Rhinitis Study In Pediatric Subjects

• Status: Completed
• Trial end date: 2005-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if the investigational drug is effective and safe in children with perennial allergic rhinitis.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion criteria:

• Diagnosis of perennial allergic rhinitis.

Exclusion criteria:

• Have significant concomitant medical conditions.

• Use of corticosteroids or other allergy medications during the study.

• Have abnormal ECG.

• Have laboratory abnormality.

• Have abnormal eye exam.